We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Agilent Technologies’ Bioinformatics Suite to Enable Standardization of Platforms at Federal Agency

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Agilent Technologies’ Bioinformatics Suite to Enable Standardization of Platforms at Federal Agency"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Agilent Technologies Inc. has announced that the National Cancer Institute (NCI) has purchased a full site license for a wide range of Agilent bioinformatics solutions.

Under the agreement, the NCI is making the following solutions available to its intramural program researchers: Agilent GeneSpring GX for gene expression, Agilent CGH Analytics for comparative genomic hybridization (CGH) studies, Agilent Chip Analytics to analyze chromatin immunoprecipitation-on-chip data (ChIP-on-chip), and GeneSpring GT for genotyping and SNP analysis.

The license, arranged under the auspices of the NCI’s Office of Science and Technology Partnerships, will enable standardization of bioinformatics platforms so that users communicate using the same terms and share comparable training and support.

“We’re proud of our close working relationship with the NCI,” said Agilent’s Jordan Stockton, gene expression marketing manager, “especially in helping their researchers employ such emerging applications as aCGH and ChIP-on-chip in conjunction with gene expression to accelerate the search for ways of controlling cancer.”

Agilent GeneSpring GX 7.3, a desktop gene-expression analysis solution, is designed to help researchers to identify targets quickly and reliably. Statistically meaningful results provide the ability to predict clinical outcomes and to characterize novel expression patterns.

Agilent CGH Analytics 3.4 lets researchers visually explore, detect and analyze aberration patterns from multiple CGH microarray profiles. Agilent ChIP Analytics 1.2 lets users visually explore and analyze data from Agilent ChIP-on-chip microarrays.

Agilent GeneSpring GT 2.0 is a desktop analysis workbench for analyzing high-volume, high-density genotyping data. A comprehensive set of linkage and association algorithms allows researchers to discover relationships between genotypes and phenotypes.

Designed for biologists and statisticians, GeneSpring GT enables analysis and visualization of hundreds of thousands of variation measurements simultaneously, for rapid localization of disease or phenotype markers.